Financial Ratios The Children's Place, Inc.
Equities
PLCE
US1689051076
Apparel & Accessories Retailers
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.39 USD | +2.52% |
|
+15.63% | +8.89% |
Feb. 05 | Children's Place Shares Surge After Mithaq Discloses Additional Stock Purchase | MT |
Dec. 31 | Children's Place Starts Rights Offering | MT |
Fiscal Period: February | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.71 | -8.69 | 16.4 | 0.11 | -2.16 | |||||
Return on Total Capital | 10.64 | -12.87 | 25.44 | 0.16 | -3.43 | |||||
Return On Equity % | 26.67 | -85.44 | 117.4 | -0.59 | -206.8 | |||||
Return on Common Equity | 26.67 | -85.44 | 117.4 | -0.59 | -206.8 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.03 | 21.89 | 41.57 | 30.09 | 27.79 | |||||
SG&A Margin | 25.56 | 28.13 | 23.6 | 26.98 | 26.88 | |||||
EBITDA Margin % | 9.47 | -6.24 | 17.96 | 3.11 | 0.91 | |||||
EBITA Margin % | 5.47 | -10.6 | 14.91 | 0.1 | -1.93 | |||||
EBIT Margin % | 5.47 | -10.6 | 14.91 | 0.1 | -1.93 | |||||
Income From Continuing Operations Margin % | 3.92 | -9.22 | 9.77 | -0.07 | -9.64 | |||||
Net Income Margin % | 3.92 | -9.22 | 9.77 | -0.07 | -9.64 | |||||
Net Avail. For Common Margin % | 3.92 | -9.22 | 9.77 | -0.07 | -9.64 | |||||
Normalized Net Income Margin | 3.16 | -7.11 | 8.71 | -0.42 | -2.37 | |||||
Levered Free Cash Flow Margin | 9.04 | -5.81 | 7.05 | -1.95 | 7.4 | |||||
Unlevered Free Cash Flow Margin | 9.31 | -5.32 | 7.66 | -1.46 | 8.57 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.96 | 1.31 | 1.76 | 1.69 | 1.79 | |||||
Fixed Assets Turnover | 4.2 | 2.78 | 4.7 | 5.22 | 5.29 | |||||
Receivables Turnover (Average Receivables) | 55.07 | 42.09 | 62.39 | 47.83 | 38.71 | |||||
Inventory Turnover (Average Inventory) | 3.85 | 3.33 | 2.74 | 2.72 | 2.86 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.76 | 0.76 | 0.98 | 0.87 | 0.73 | |||||
Quick Ratio | 0.17 | 0.14 | 0.13 | 0.1 | 0.08 | |||||
Operating Cash Flow to Current Liabilities | 0.3 | -0.05 | 0.23 | -0.01 | 0.15 | |||||
Days Sales Outstanding (Average Receivables) | 6.61 | 8.65 | 5.83 | 7.61 | 9.58 | |||||
Days Outstanding Inventory (Average Inventory) | 94.44 | 109.46 | 132.85 | 133.58 | 129.82 | |||||
Average Days Payable Outstanding | 59.91 | 67.72 | 68.39 | 54.14 | 69.71 | |||||
Cash Conversion Cycle (Average Days) | 41.13 | 50.39 | 70.29 | 87.06 | 69.69 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 257.07 | 678.84 | 199.96 | 322.95 | -5.14K | |||||
Total Debt / Total Capital | 71.99 | 87.16 | 66.66 | 76.36 | 101.98 | |||||
LT Debt/Equity | 132.62 | 310.05 | 81.8 | 92.27 | -1.86K | |||||
Long-Term Debt / Total Capital | 37.14 | 39.81 | 27.27 | 21.82 | 36.91 | |||||
Total Liabilities / Total Assets | 80.09 | 91.81 | 78.27 | 83.93 | 101.13 | |||||
EBIT / Interest Expense | 12.5 | -13.56 | 15.33 | 0.13 | -1.03 | |||||
EBITDA / Interest Expense | 47.65 | 6.51 | 26.7 | 15.39 | 4.98 | |||||
(EBITDA - Capex) / Interest Expense | 40.63 | 3.94 | 25.12 | 11.97 | 4.06 | |||||
Total Debt / EBITDA | 1.55 | 8.18 | 0.91 | 2.5 | 3.1 | |||||
Net Debt / EBITDA | 1.37 | 7.36 | 0.8 | 2.41 | 3.01 | |||||
Total Debt / (EBITDA - Capex) | 1.82 | 13.52 | 0.96 | 3.21 | 3.79 | |||||
Net Debt / (EBITDA - Capex) | 1.61 | 12.16 | 0.85 | 3.1 | 3.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.48 | -18.61 | 25.8 | -10.8 | -6.2 | |||||
Gross Profit, 1 Yr. Growth % | -4.14 | -49.15 | 94.82 | -35.3 | -13.4 | |||||
EBITDA, 1 Yr. Growth % | -4.9 | -153.61 | 6.5K | -84.48 | -74.64 | |||||
EBITA, 1 Yr. Growth % | -12.8 | -257.61 | -566.85 | -99.39 | -629.61 | |||||
EBIT, 1 Yr. Growth % | -12.8 | -257.61 | -566.85 | -99.39 | -629.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -27.4 | -291.49 | -233.35 | -100.61 | 13.48K | |||||
Net Income, 1 Yr. Growth % | -27.4 | -291.49 | -233.35 | -100.61 | 13.48K | |||||
Normalized Net Income, 1 Yr. Growth % | -17.59 | -283.4 | -465.65 | -104.33 | 721.7 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % |